1.
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol
2.
3.
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up
SARS-CoV-2 seroprevalence among nursing home residents and staff in Belgium : results visit 1 : februari 2021
SARS-CoV-2 seroprevalence among nursing home residents and staff in Belgium in August 2021 : brief communication on preliminary results of the SCOPE study
SARS-CoV-2 seroprevalence among nursing home residents and staff in Belgium : results visit 2 : april 2021
Effect of booster dose on the prevalence of anti-SARS-CoV-2 antibodies among nursing home residents : brief communication on results of the SCOPE study : december 2021
Declining prevalence of SARS-CoV-2 antibodies among vaccinated nursing home residents and staff six months after the primary BNT162b2 vaccination campaign in Belgium : a prospectiv...
Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective...